Replies to post #142682 on Biotech Values

[acgood]

ALNY and ISIS have not gone into specifics of TTR pivotal trial design - both are saying that they are still in discussions with regulators and KOLs. ALNY is also running a phase 2 trial in patients first before pivotal.